ARCHIVES

NCI Exceeded Mandate In Study Of Legislators, Rep. Porter Says

This article is from The Cancer Letter archive.

Vol. 21 No. 32 | August 11, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

Deborah Mayer Appointed To NCAB; Cancer Panel Plans Meetings For July 9

May 10, 1991

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995